RTW Biotech Opportunities (LON:RTW – Get Free Report) shares rose 1.2% during trading on Wednesday . The company traded as high as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). Approximately 495,137 shares changed hands during trading, an increase of 129% from the average daily volume of 215,884 shares. The stock had previously closed at GBX 1.25 ($0.02).
RTW Biotech Opportunities Trading Up 1.2 %
The company has a fifty day moving average price of GBX 1.34 and a two-hundred day moving average price of GBX 1.45. The firm has a market capitalization of £423.25 million, a PE ratio of 3.00 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Further Reading
- Five stocks we like better than RTW Biotech Opportunities
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Airline Stocks – Top Airline Stocks to Buy Now
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is an Earnings Surprise?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
